Status:

UNKNOWN

Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease

Lead Sponsor:

Hawaii Pacific Health

Conditions:

Kawasaki Disease

Coronary Aneurysm

Eligibility:

All Genders

1-21 years

Phase:

PHASE2

Brief Summary

Kawasaki disease (KD) affects infants and young children causing inflammation of the skin and blood vessels including the coronary arteries of the heart. Despite the currently available therapy, about...

Detailed Description

This research study attempts to reveal whether coronary artery dilation in patients with Kawasaki disease refractory to standard therapy could be prevented using a matrix metalloproteinase inhibitor: ...

Eligibility Criteria

Inclusion

  • Treatment arm: Patients aged 1 month to 21 years with confirmed KD will be included in the study if they meet the following criteria:
  • Patients with dilation of the right or left anterior descending coronary artery beyond a z-score of +2.5 during the acute febrile phase of KD.
  • Patients with aneurysms of the right or left main coronary arteries during the acute febrile phase of KD.
  • Patients with refractory KD after initial treatment with IVIG and dilated coronary arteries on an echocardiogram during the first month of KD.
  • Comparison arm: Patients aged 1 month to 18 years with confirmed KD, who do not meet inclusion criteria to be included in the treatment group.
  • Patients with right or left anterior descending coronary artery measurements below a z-score of +2.5 during the acute febrile phase of KD.

Exclusion

  • The following patients will be excluded from this study:
  • Patients with clinically incomplete KD.
  • Patients whose parents refuse to administer doxycycline.
  • Patients with acute renal failure.
  • Patients with chronic liver and kidney disease.

Key Trial Info

Start Date :

October 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2022

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT01917721

Start Date

October 1 2013

End Date

November 1 2022

Last Update

August 28 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kapiolani Medical Center for Women and Children

Honolulu, Hawaii, United States, 96826